VALENCIA, Calif., May 7 /PRNewswire-FirstCall/ -- MannKind Corporation (NASDAQ:MNKD), focused on discovering, developing and commercializing treatments for diabetes and cancer, announced today that it will present at upcoming conferences.
-- Bank of America Health Care Conference on Wednesday, May 14, 2008 at
8:40 AM (Pacific Time) at the Four Seasons Hotel, Las Vegas, Nevada
-- Baird's 2008 Growth Stock Conference on Thursday, May 15, 2008 at
8:55 AM (Central Time) at the Four Seasons Hotel, Chicago, Illinois
-- UBS Global Specialty and Generic Pharmaceuticals Conference on
Thursday, May 29, 2008 at 9:30 AM (London Time) at The Waldorf Hilton,
Aldwych, London
Interested parties can access a link to the live web cast of the presentations in the Investor Relations section of the Company's website at http://www.mannkindcorp.com/. A replay of each presentation will be available for 14 days.
About MannKind Corporation MannKind Corporation (NASDAQ:MNKD) focuses on the discovery, development and commercialization of therapeutic products for diseases such as diabetes and cancer. Its lead product, the Technosphere(R) Insulin System, is currently in phase 3 clinical trials in the United States, Europe and Latin America to study its safety and efficacy in the treatment of diabetes. For more information on MannKind Corporation and its technology, visit http://www.mannkindcorp.com/. DATASOURCE: MannKind Corporation CONTACT: Matthew Pfeffer, Chief Financial Officer of MannKind Corporation, +1-661-295-4784, Web site: http://www.mannkindcorp.com/
|